Mercado de medicamentos derivados de plantas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00021201
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Plant Derivative Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

INTRODUCCIÓN AL MERCADO Desde la antigüedad, las plantas medicinales, también conocidas como hierbas medicinales, se han encontrado y utilizado en las prácticas de la medicina tradicional. Para protegerse contra insectos, hongos, enfermedades y mamíferos herbívoros, las plantas sintetizan cientos de compuestos químicos. Se han identificado numerosos fitoquímicos con actividad biológica potencial o establecida. DINÁMICA DEL MERCADO El mercado de medicamentos derivados de plantas está impulsando debido a la prevalencia del aumento de enfermedades crónicas e infecciosas (enfermedades de la piel y enfermedades gastrointestinales) y al aumento de la resistencia a los medicamentos. Además, el avance tecnológico brinda oportunidades de crecimiento a los fabricantes de medicamentos derivados de plantas. ALCANCE DEL MERCADO El "Análisis del mercado de medicamentos derivados de plantas hasta 2031" es un estudio especializado y en profundidad de la industria de la salud con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de medicamentos derivados de plantas con una segmentación detallada del mercado por tipo, aplicación terapéutica, tipo de dosificación, usuario final y canal de distribución. Se espera que el mercado de medicamentos derivados de plantas sea testigo de un alto crecimiento durante el período de pronóstico. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores en el mercado de medicamentos derivados de plantas y ofrece tendencias y oportunidades clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado de medicamentos derivados de plantas está segmentado en tipo, aplicación terapéutica, tipo de dosificación, usuario final y canal de distribución. Según el tipo, el mercado se segmenta en terpenos, esteroides, glucósidos, fenoles y otros. Según la aplicación terapéutica, el mercado se segmenta en oncología, dermatología, trastornos del sistema nervioso central, enfermedades infecciosas, enfermedades cardiovasculares, enfermedades respiratorias y otras. Según el tipo de dosis, el mercado se segmenta en oral, líquido y parenteral. Según el usuario final, el mercado se segmenta en hospitales, clínicas especializadas, atención médica domiciliaria y otros. Según el canal de distribución, el mercado se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias en línea.

Plant Derivative Drugs Market: Strategic Insights

Plant Derivative Drugs Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • ABBOTT LABORATORIES
  • BAYER
  • BOEHRINGER INGELHEIM
  • BRISTOL MYERS SQUIBB
  • CARDAX PHARMACEUTICALS
  • CHONG KUN DANG PHARMACEUTICAL CORP
  • FYTOKEM PRODUCTS INC
  • GALAPAGOS NV
  • GLAXOSMITHKLINE

Regional Overview

Regional And Country Scope
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

Segment 1Tipo
  • Terpenos
  • Esteroides
  • Glucósidos
  • Fenoles
  • Otros
Segment2Aplicación Terapéutica
  • Oncología
  • Dermatología
  • Trastornos del Sistema Nervioso Central
  • Enfermedades Infecciosas
  • Enfermedades Cardiovasculares
  • Enfermedades Respiratorias
  • Otras
Segment3Tipo de dosis
  • oral
  • líquida
  • parenteral
Segment4Usuario final
  • hospitales
  • clínicas especializadas
  • atención médica domiciliaria
  • otros
El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y un pronóstico del mercado de medicamentos derivados de plantas en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico para el año 2021 al 2031 con respecto a cinco regiones principales, a saber, América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado de medicamentos derivados de plantas de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 18 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región. El informe analiza los factores que afectan el mercado de medicamentos derivados de plantas tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, los impulsores, las restricciones, las oportunidades y las tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber, América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de medicamentos derivados de plantas en estas regiones. JUGADORES DEL MERCADO El informe cubre desarrollos clave en el mercado de medicamentos derivados de plantas como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado de medicamentos derivados de plantas tendrán oportunidades de crecimiento lucrativas en el futuro con la creciente demanda del mercado de medicamentos derivados de plantas en el mercado global. A continuación se menciona la lista de algunas empresas que participan en el mercado de medicamentos derivados de plantas. El informe también incluye los perfiles de actores clave en el mercado de Medicamentos derivados de plantas junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años.
    •  LABORATORIOS ABBOTT •  BAYER •  BOEHRINGER INGELHEIM •  BRISTOL-MYERS SQUIBB •  FARMACÉUTICOS CARDAX •  CHONG KUN DANG PHARMACEUTICAL CORP •  PRODUCTOS FYTOKEM INC. •  GALÁPAGOS NV •  GLAXOSMITHKLINE •  GLENMARK PHARMACEUTICALS LIMITED
El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.

Plant Derivative Drugs Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo
  • Terpenos
  • Esteroides
  • Glucósidos
  • Fenoles
  • Otros
By Aplicación Terapéutica
  • Oncología
  • Dermatología
  • Trastornos del Sistema Nervioso Central
  • Enfermedades Infecciosas
  • Enfermedades Cardiovasculares
  • Enfermedades Respiratorias
  • Otras
By Tipo de dosis
  • oral
  • líquida
  • parenteral
By Usuario final
  • hospitales
  • clínicas especializadas
  • atención médica domiciliaria
  • otros
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • resto de Europa
Asia-Pacífico
  • China
  • India
  • Japón
  • Australia
  • resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Market leaders and key company profiles
  • ABBOTT LABORATORIES
  • BAYER
  • BOEHRINGER INGELHEIM
  • BRISTOL MYERS SQUIBB
  • CARDAX PHARMACEUTICALS
  • CHONG KUN DANG PHARMACEUTICAL CORP
  • FYTOKEM PRODUCTS INC
  • GALAPAGOS NV
  • GLAXOSMITHKLINE
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. ABBOTT LABORATORIES
    2. BAYER
    3. BOEHRINGER INGELHEIM
    4. BRISTOL-MYERS SQUIBB
    5. CARDAX PHARMACEUTICALS
    6. CHONG KUN DANG PHARMACEUTICAL CORP
    7. FYTOKEM PRODUCTS INC.
    8. GALAPAGOS NV
    9. GLAXOSMITHKLINE
    10. GLENMARK PHARMACEUTICALS LIMITED
    11. Hsrx Biopharmaceutical
    12. Indena
    13. Izun Pharmaceuticals Corp.
    14. Lupin Pharmaceuticals Inc.
    15. Medigene Ag
    16. Merck & Co. Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..